Biotricity Price to Book Ratio 2015-2025 | BTCY
Historical price to book ratio values for Biotricity (BTCY) over the last 10 years. The current price to book ratio for Biotricity as of June 19, 2026 is 0.00.
| Biotricity Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-06-17 | 0.12 | 0.00 | |
| 2025-12-31 | 0.30 | $-1.23 | -0.24 |
| 2025-09-30 | 0.53 | $-1.25 | -0.42 |
| 2025-06-30 | 0.37 | $-1.23 | -0.30 |
| 2025-03-31 | 0.34 | $-1.23 | -0.28 |
| 2024-12-31 | 0.29 | $-1.31 | -0.22 |
| 2024-09-30 | 0.24 | $-1.36 | -0.17 |
| 2024-06-30 | 0.90 | $-1.39 | -0.65 |
| 2024-03-31 | 1.48 | $-3.36 | -0.44 |
| 2023-12-31 | 1.15 | $-3.00 | -0.38 |
| 2023-09-30 | 2.14 | $-3.12 | -0.69 |
| 2023-06-30 | 3.83 | $-0.46 | -8.34 |
| 2023-03-31 | 2.79 | $-2.33 | -1.20 |
| 2022-12-31 | 2.69 | $-1.83 | -1.47 |
| 2022-09-30 | 4.80 | $-1.26 | -3.80 |
| 2022-06-30 | 10.62 | $-0.76 | -13.95 |
| 2022-03-31 | 13.62 | $-0.26 | -52.73 |
| 2021-12-31 | 23.88 | $0.28 | 85.22 |
| 2021-09-30 | 17.64 | $0.95 | 18.56 |
| 2021-06-30 | 18.87 | $-1.62 | -11.67 |
| 2021-03-31 | 14.37 | $-1.13 | -12.67 |
| 2020-12-31 | 4.43 | $-1.70 | -2.61 |
| 2020-09-30 | 6.66 | $-1.19 | -5.58 |
| 2020-06-30 | 8.20 | $-0.80 | -10.20 |
| 2020-03-31 | 5.84 | $-0.49 | -11.81 |
| 2019-12-31 | 3.78 | $-0.32 | -11.96 |
| 2019-09-30 | 3.48 | $-0.81 | -4.27 |
| 2019-06-30 | 3.96 | 0.00 | |
| 2019-03-31 | 5.46 | $-2.47 | -2.21 |
| 2018-12-31 | 2.88 | 0.00 | |
| 2018-09-30 | 11.46 | 0.00 | |
| 2018-06-30 | 18.96 | 0.00 | |
| 2018-03-31 | 22.14 | $0.13 | 173.38 |
| 2017-12-31 | 45.54 | 0.00 | |
| 2017-09-30 | 13.08 | 0.00 | |
| 2017-06-30 | 16.20 | 0.00 | |
| 2017-03-31 | 15.06 | 0.00 | |
| 2016-12-31 | 15.48 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.014B |
| Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |